The Securities and Exchange Commission (SEC) and Department of Justice (DOJ) have ended a seven-year review of GE HealthCare Technologies’ China unit for possible violations of the Foreign Corrupt Practices Act (FCPA), the company announced.

Learn More
Already a member? Sign in to an existing account.

Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government. Email: adrianne.appel@complianceweek.com LinkedIn:...